Morbidity and mortality in the italian gastric cancer study group randomized clinical trial of D1 versus D2 resection for gastric cancer

British Journal of Surgery

Volumn 97, Issue 5, 2010, Pages 643-649

  Degiuli, M ^a   Sasako, M ^b   Ponti, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; ITALY; LENGTH OF STAY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HOSPITAL MORTALITY; HUMANS; ITALY; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STOMACH NEOPLASMS;

EID: 77951839572     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6936     Document Type: Article

References (31)

1. Fujii M, Sasaki. J, Nakajima T. State of me art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2: 151-157.
2. Sasako M. D2 nodal dissection. Operative Techniques in General Surgery 2003; 5: 36-49.
3. Kinoshita T, Maruyama K, Sasako M, Okajima K. Treatment results of gastric cancer patients: Japanese experience. In Gastric Canter, Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E (eds). Springer: Tokyo, 1993; 319-330.
4. Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma: results of the German Gastric Carcinoma study 1992. Cancer 1993; 72: 2089-2097. (Pubitemid 23280131)
5. Smith JW, Shiu MH, Kelsey L, Brennan MF. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991; 126: 1469-1473.
6. Sue-ling HM. Radical surgery is essential for treating gastric cancer. Eur J Surg Oncol 1994; 20: 179-182. (Pubitemid 24164477)
7. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, PlukkerJT et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748.
8. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I et al. Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340: 908-914.
9. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V et al. Postoperative morbidity and mortality after Dl and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347: 995-999. (Pubitemid 26112171)
10. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79:1522-1530. (Pubitemid 29116815)
11. NHS Executive. Guidance on Commissioning Cancer Services: bnproving Outtomes in Upper Gastro-intestinal Cancers. http://www.dh.gov.uk/assetRoot/04/ 08/02/78/04080278.pdf [accessed 18 February 2009].
12. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006; 7: 309-315.
13. Hartgrink HH, Van de Velde CJH. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Ontol 2005; 90: 153-165. (Pubitemid 40741180)
14. Van de Velde CJH, Peters KCMJ. The gastric cancer treatment controversy. J Clin Oncal 2003; 21: 2234-2236.
15. Edwards P, Blackshaw GRJC, Lewis WG, Barry JD, Allison MC, Jones DRB. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 2004; 90: 1888-1892. (Pubitemid 38746326)
16. Hartgrink HH, Van de Velde CJH, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 2004; 22: 2069-2077.
17. Degiuli M, Sasako M, Ponti A, Soldati T, Danese F, Calvo F et al. Morbidity and mortality after D2 gastrectomy for gastric cancer. Results of the Italian Gastric Cancer Study Group Prospective Multicenter Surgical Study. J Clin Oncol 1998; 16: 1490-1493. (Pubitemid 28175770)
18. Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. BrJ Cancer 2004; 90: 1727-1732. (Pubitemid 38725642)
19. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998; 1: 10-24.
20. Kajitani T. The general rules for the Gastric Cancer Study in Surgery and Pathology. Part 1. Clinical classification. Jpn J Surg1981;11: 127-139.
21. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995; 19: 532-536.
22. Sasako M, Sano T, Katai H, Maruyama K. Radical surgery. In Gastric Cancer, Sugimura T, Sasako M (eds). Oxford University Press: Oxford, 1997; 223-245.
23. Sobin LH, Wittekind C (eds). International Union Against Cancer (UICC). TNM Classification of Malignant Tumors (5th edn). John Wiley: New York, 1997.
24. Bunt AMG, Hermans J, Boon MC, Van de Velde CJH, Sasako M, Fleuren GJ et al. Evaluation of the extent of lymphadenectomy in a randomised trial of western vs Japanese-type surgery in gastric cancer. J Clin Oncol 1994; 12:417-422. (Pubitemid 24056418)
25. Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M et al; Italian Gastric Cancer Study Group. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004;30:303-308. (Pubitemid 38425649)
26. European Medicines Agency (EMEA). Committee for Medicinal Pnducts for Human Use (CHMP) Guideline on the Choice of the Non-inferiority Margin. EMEA: London, 2005.
27. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004; 91: 283-287. (Pubitemid 38375766)
28. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomised controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004; 22: 2767-2773. (Pubitemid 41079893)
29. Bonenkamp JJ, Van de Velde CJH, Kampshöer GH, Hermans J, Hermanek P, Bemelmans M et al. Comparison of factors influencing the prognosis of Japanese, German and Dutch gastric cancer patients. World J Surg 1993; 17: 410-415. (Pubitemid 23187745)
30. McCulloch P. Should general surgeons treat gastric carcinoma? An audit of practice and results 1980-1985. BrJ Surg 1994; 81: 417-420.
31. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery .JAMA 1998; 280: 1747-1751. (Pubitemid 28536874)